Skip to main content
. Author manuscript; available in PMC: 2021 Mar 6.
Published in final edited form as: Leukemia. 2020 Jun 18;35(3):850–862. doi: 10.1038/s41375-020-0922-x

Figure 2: Probability of neutrophil recovery after haplo-dCBT by engraftment group (Groups 1–3, n = 75).

Figure 2:

Figure 2A: Group 1 patients (n = 34) had early sustained myeloid recovery by day 14 post-transplant (median 12 days).

Figure 2B: Group 2 patients (n = 20) had transient myeloid recovery (median neutrophil recovery 12 days) followed by a second nadir preceding sustained engraftment (median second neutrophil recovery 26.5 days).

Figure 2C: Percentage of Group 2 patients with a neutrophil count ≥ 500/dL per post-transplant day.

Figure 2D: Group 3 patients (n = 21) had delayed myeloid recovery (median 25 days).